Rite Aid Corp. (NYSE: RAD) blamed higher drug expenses along with lower reimbursement rates for lowering its 2015 earnings outlook. The stock price lost 63 cents to close at $7.87.
Rite Aid lowers outlook
June 05, 2014 at 17:43 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.